Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 2:55 pm Purchase |
2021-12-31 | 13G | SCYNEXIS, Inc. SCYX |
FEDERATED HERMES INC. FHI |
5,915,664 19.990% |
466,411 (+8.56%) |
Filing History |
| 2022-02-14 2:53 pm Purchase |
2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
FEDERATED HERMES INC. FHI |
2,803,335 5.580% |
1,027,631 (+57.87%) |
Filing History |
| 2022-02-14 2:44 pm Unchanged |
2021-12-31 | 13G | Rezolute, Inc. RZLT |
FEDERATED HERMES INC. FHI |
3,189,222 20.660% |
0 (Unchanged) |
Filing History |
| 2022-02-14 1:54 pm Purchase |
2021-12-31 | 13G | P10, Inc. PX |
FEDERATED HERMES INC. FHI |
2,822,860 12.270% |
46,357 (+1.67%) |
Filing History |
| 2022-02-14 1:53 pm Sale |
2021-12-31 | 13G | Baozun Inc. BZUN |
FEDERATED HERMES INC. FHI |
28,838,088 12.380% |
-1,145,238 (-3.82%) |
Filing History |
| 2022-02-14 1:53 pm Unchanged |
2021-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
FEDERATED HERMES INC. FHI |
1,201,275 22.500% |
0 (Unchanged) |
Filing History |
| 2022-02-14 1:48 pm Purchase |
2021-12-31 | 13G | Xponential Fitness, Inc. XPOF |
FEDERATED HERMES INC. FHI |
1,400,000 5.860% |
1,400,000 (New Position) |
Filing History |
| 2022-02-14 1:46 pm Purchase |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
6,914,136 7.530% |
6,914,136 (New Position) |
Filing History |
| 2022-02-14 1:43 pm Purchase |
2021-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
FEDERATED HERMES INC. FHI |
2,290,282 5.950% |
2,290,282 (New Position) |
Filing History |
| 2022-02-14 1:40 pm Purchase |
2021-12-31 | 13G | Domo, Inc. DOMO |
FEDERATED HERMES INC. FHI |
1,713,217 5.840% |
1,713,217 (New Position) |
Filing History |
| 2022-02-14 1:38 pm Sale |
2021-12-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
2,358,624 12.230% |
-88,376 (-3.61%) |
Filing History |
| 2022-02-14 1:37 pm Purchase |
2021-12-31 | 13G | Annexon, Inc. ANNX |
FEDERATED HERMES INC. FHI |
2,025,600 5.280% |
2,025,600 (New Position) |
Filing History |
| 2022-02-14 1:35 pm Purchase |
2021-12-31 | 13G | Akouos, Inc. AKUS |
FEDERATED HERMES INC. FHI |
2,498,442 7.240% |
178,960 (+7.72%) |
Filing History |
| 2022-02-14 1:34 pm Purchase |
2021-12-31 | 13G | AnaptysBio, Inc. ANAB |
FEDERATED HERMES INC. FHI |
1,604,287 5.800% |
330,520 (+25.95%) |
Filing History |
| 2022-02-14 1:31 pm Purchase |
2021-12-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
5,280,847 6.500% |
998,284 (+23.31%) |
Filing History |
| 2022-02-14 1:29 pm Purchase |
2021-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
3,464,335 7.240% |
238,452 (+7.39%) |
Filing History |
| 2022-02-14 1:26 pm Purchase |
2021-12-31 | 13G | Orchard Therapeutics plc ORTX |
FEDERATED HERMES INC. FHI |
830,986 6.620% |
830,986 (New Position) |
Filing History |
| 2022-02-14 1:26 pm Unchanged |
2021-12-31 | 13G | aTyr Pharma, Inc. LIFE |
FEDERATED HERMES INC. FHI |
5,222,250 18.790% |
0 (Unchanged) |
Filing History |
| 2022-02-14 1:24 pm Purchase |
2021-12-31 | 13G | Omega Alpha SPAC OMEG |
FEDERATED HERMES INC. FHI |
1,000,000 6.990% |
1,000,000 (New Position) |
Filing History |
| 2022-02-14 1:23 pm Unchanged |
2021-12-31 | 13G | BCLS Acquisition Corp. BLSA |
FEDERATED HERMES INC. FHI |
1,000,000 6.730% |
0 (Unchanged) |
Filing History |